Signition LP’s AbbVie ABBV Stock Holding History

Signition LP’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,849	Closed	-$270K	–	251
2018 Q1	$270K	Buy	+2,849	New	+$313K	0.33%	83

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Signition LP's ABBV Position: Q2 2018 in Review

Signition LP sold out of AbbVie (ABBV) in Q2 2018, closing a stake of 2,849 shares — an estimated $270K sold.

Signition LP first reported a position in ABBV in Q1 2018 and held it in 1 quarter. The position peaked at $270K in Q1 2018. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

Signition LP reported no remaining AbbVie position as of Q2 2018 after selling out during the quarter.
Signition LP sold 2,849 AbbVie shares in Q2 2018, an estimated $270K.
Signition LP first reported a position in AbbVie in Q1 2018 and held it in 1 quarter.
Signition LP's AbbVie position peaked at $270K in Q1 2018.
1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Signition LP's 13F filing for Q2 2018, filed 6 Aug 2018.